Form 4 for CRMD CorMedix Inc.
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0001213900-25-112316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-18 | 2025-11-14 | CRMD | Dillione Janet | Dir | S - Sale | $11.42 | -30.0K | 48.5K | -38% | -$342.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-14 | S | D | 30,000 | $11.42 | 48,473 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $11.41 to $11.44, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |